![Qiagen Moves into Neurology with Recent Collaboration](https://www.g2intelligence.com/wp-content/uploads/2022/09/Oct22.LIR_.DXDeals-iStock-1800x1250-1-1080x675.jpg)
Qiagen Moves into Neurology with Recent Collaboration
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.
Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.